WHERE HEALTH SYSTEMS & LIFE SCIENCES CONNECT

Loopback is founded with a core mission to improve healthcare outcomes through data. Initial efforts focus on hospital readmissions, laying the groundwork for long-term impact in care delivery and quality measurement.

Secures seed funding and launches its foundational Loopback Data Platform, built on a proprietary common data model to aggregate, normalize, and integrate data across systems. From the start, Loopback prioritizes data security and compliance with a framework designed to meet and exceed HIPAA requirements.

Strategically focuses business on health system specialty pharmacies (HSSPs), recognizing an unmet need for data analytics capabilities to provide insight into medication access, adherence, and outcomes.

Launches Rx Capture to measure prescription capture and Rx Outcomes to track adherence across defined patient cohorts.

Launches life sciences business and contributes critical clinical data to an FDA research poster developed in collaboration with the Center for Devices and Radiological Health. The resulting research is featured at the 2021 FDA Science Forum.

Introduces TSOC, bringing together leading health system specialty pharmacies on the Loopback Data Platform to share therapy-specific best practices and improve access to LDDs and payor networks.

Receives strategic investment from PSG, fueling scale across both health systems and life sciences. Named a Fast 50 company and Best Place to Work by the Dallas Business Journal in November 2023.

Acquires Acentrus Specialty’s Limited Drug Distribution (LDD) access services, expanding market access capabilities and deepening relationships with manufacturers. This acquisition accelerates Loopback’s evolution into a fully integrated ecosystem partner.

Introduces the new name Loopback Health, reflecting our broader mission and a unified approach to supporting both health systems and life sciences partners.